Boston Scientific Corp (BSX)
86.99
-0.60
(-0.68%)
USD |
NYSE |
Nov 15, 16:00
86.55
-0.44
(-0.51%)
After-Hours: 20:00
Boston Scientific Research and Development Expense (TTM): 1.519B for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.519B |
| June 30, 2024 | 1.468B |
| March 31, 2024 | 1.444B |
| December 31, 2023 | 1.415B |
| September 30, 2023 | 1.382B |
| June 30, 2023 | 1.365B |
| March 31, 2023 | 1.341B |
| December 31, 2022 | 1.323B |
| September 30, 2022 | 1.313B |
| June 30, 2022 | 1.284B |
| March 31, 2022 | 1.247B |
| December 31, 2021 | 1.204B |
| September 30, 2021 | 1.17B |
| June 30, 2021 | 1.175B |
| March 31, 2021 | 1.119B |
| December 31, 2020 | 1.143B |
| September 30, 2020 | 1.165B |
| June 30, 2020 | 1.156B |
| March 31, 2020 | 1.194B |
| December 31, 2019 | 1.174B |
| September 30, 2019 | 1.154B |
| June 30, 2019 | 1.137B |
| March 31, 2019 | 1.132B |
| December 31, 2018 | 1.113B |
| September 30, 2018 | 1.088B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.053B |
| March 31, 2018 | 1.022B |
| December 31, 2017 | 996.00M |
| September 30, 2017 | 989.00M |
| June 30, 2017 | 967.00M |
| March 31, 2017 | 945.00M |
| December 31, 2016 | 920.00M |
| September 30, 2016 | 908.00M |
| June 30, 2016 | 897.00M |
| March 31, 2016 | 895.00M |
| December 31, 2015 | 877.00M |
| September 30, 2015 | 841.00M |
| June 30, 2015 | 832.00M |
| March 31, 2015 | 818.00M |
| December 31, 2014 | 817.00M |
| September 30, 2014 | 826.00M |
| June 30, 2014 | 831.00M |
| March 31, 2014 | 848.00M |
| December 31, 2013 | 861.00M |
| September 30, 2013 | 882.00M |
| June 30, 2013 | 885.00M |
| March 31, 2013 | 875.00M |
| December 31, 2012 | 886.00M |
| September 30, 2012 | 878.00M |
| June 30, 2012 | 887.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
1.119B
Minimum
Mar 2021
1.519B
Maximum
Sep 2024
1.280B
Average
1.266B
Median
Research and Development Expense (TTM) Benchmarks
| Baxter International Inc | 754.00M |
| Haemonetics Corp | 60.10M |
| ResMed Inc | 311.34M |
| Globus Medical Inc | 182.60M |
| Abbott Laboratories | 2.795B |